Table 4.
Study | Population | Methodology | Outcome | Recurrence rate | Risk factors for recurrence |
---|---|---|---|---|---|
Crum-Cianflone et al. [10] | 31 subjects with initial MRSA SSTI | Retrospective, single center | Any recurrent SSTI | 41 % (all SSTI) | Lower CD4 counta |
21 % (MRSA SSTI) | Higher viral loadab | ||||
Lack of incision and drainageab | |||||
Positive nare culturea | |||||
Crum-Cianflone et al. [26] | 379 subjects with initial SSTI | Prospective, multi-center | Any recurrent SSTI | 31 % | No significant risk factor identified |
Trend toward viral load and dermatologic condition predicting SSTI recurrence | |||||
Graber et al. [9] | 62 subjects with initial MRSA SSTI | Retrospective, single center | Any recurrent SSTI | 71 % | No significant risk factor identified |
Vyas et al. [11] | 63 individuals with initial MRSA SSTI | Retrospective, single center | Recurrent MRSA SSTI | 27 % | Older agea |
Lower CD4 count at initial SSTIab | |||||
Lower nadir CD4 counta | |||||
Higher peak viral loada | |||||
Prior AIDS defining illnessa | |||||
History of malignancya | |||||
IVDU* | |||||
Use of antibiotic other than minocyclineab | |||||
Hospital admissionab | |||||
Surgerya | |||||
Skiest et al. [12] | 41 subjects with initial MRSA SSTI | Prospective, single center | Any recurrent SSTI | 29.7 % | No significant risk factor identified |
Present study | 85 subjects with initial SSTI | Retrospective, single center | Any recurrent SSTI | 35 % (raw) | Catheterab |
Non-viral liver diseaseab | |||||
Non-African American raceab | |||||
Lymphedemaa | |||||
IVDUb |
aUnivariate analysis
bMultivariate analysis